Blog

Oct 11, 2016

First human clinical trial for nicotinamide riboside

Posted by in categories: biotech/medical, health, life extension

(credit: iStock)

In the first controlled clinical trial of nicotinamide riboside (NR), a newly discovered form of Vitamin B3, researchers have shown that the compound is safe for humans and increases levels of a cell metabolite called NAD+ that is critical for cellular energy production and protection against stress and DNA damage.

Levels of NAD+ (first discovered by biochemists in 1906) diminish with age, and it has been suggested that loss of this metabolite may play a role in age-related health decline.

Read more

Comments are closed.